Загрузка...
Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
AIMS: Familial hypertrophic cardiomyopathy (HCM) is one the most common heart disorders, with gene mutations in the cardiac sarcomere. Studying HCM with patient-specific induced pluripotent stem-cell (iPSC)-derived cardiomyocytes (CMs) would benefit the understanding of HCM mechanism, as well as the...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4217687/ https://ncbi.nlm.nih.gov/pubmed/25209314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvu205 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|